#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine cell hyperplasia of infancy Acute on chronic liver failure Encephalopathy neonatal Biotinidase deficiency Thrombotic microangiopathy Nasopharyngeal cancer Haematological malignancy Ventricular fibrillation Demyelination Small intestine leiomyosarcoma Short-bowel syndrome Intracranial germ cell tumour Alveolar proteinosis Osteosarcoma metastatic Obesity More trials…

    Learn about Rare Diseases

    Osteosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia refractory Thrombotic thrombocytopenic purpura Familial haemophagocytic lymphohistiocytosis – Life with Disease Burkitt’s lymphoma – Diagnostics Gastrointestinal stromal tumour – Basic Information Choroid melanoma – Treatment Lymphatic malformation – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Leiomyosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5764227 Argatroban Monohydrate Sufentanil Citrate Empasiprubart Deupirfenidone LVT-001 Vidutolimod Casirivimab Falbikitug Floxuridine GSKVX000000034797 Romidepsin Carbidopa Linaclotide Codeine Phosphate Iptacopan Semaglutide Levobupivacaine Oritavancin ANXV More therapies…

    Learn about Your Condition

    Neuromyopathy Cervix carcinoma Oropharyngeal cancer Crohn's disease Peritoneal dialysis Glioblastoma Malabsorption Ependymoma Urinary tract infection Pharyngeal cancer stage I Aplastic anaemia Cognitive disorder Insomnia Mitral valve disease Merycism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Finland Germany Hungary Italy Poland Portugal +1

  • Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Italy Luxembourg Poland Spain

  • Study on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Gs-1427
    Austria Belgium Czechia France Germany Hungary +4

  • Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Abelacimab
    • Apixaban
    Austria Czechia France Germany Hungary Ireland +6

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Abelacimab
    • Dalteparin Sodium
    Austria Czechia France Germany Hungary Ireland +6

  • Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic gastroparesis
    • Impaired gastric emptying
    Investigated Drugs:
    • Naronapride Dihydrochloride Trihydrate
    Austria Belgium France Germany Italy Latvia +2

  • Study on Preventing Respiratory Issues from RSV Bronchiolitis in Preterm Babies Using Palivizumab

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus bronchiolitis
    Investigated Drugs:
    • Palivizumab
    Italy

  • Study Comparing Bortezomib, Melphalan, Prednisone, Lenalidomide, and Daratumumab for Multiple Myeloma in Patients Ineligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Sodium Phosphate
    Italy

  • Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ibrutinib
    Czechia France Hungary Italy Poland Spain +1

  • Study on the Safety and Effectiveness of Adalimumab and Etanercept in Children with Active Juvenile Idiopathic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Etanercept
    • Adalimumab
    Italy
Previous Page
1 … 25 26 27 28 29 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!